SCHEMBL7326535

SCHEMBL7326535

COC(=O)Cc1ccc(C(=O)CCl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.56
CYP4A11 Q02928 1/20 0.56
ALDH1A1 P00352 8/20 0.56
RAB9A P51151 4/20 0.56
MAPT P10636 3/20 0.56
POLB P06746 2/20 0.56
SMN1; SMN2 Q16637 4/20 0.50
GSK3B P49841 2/20 0.50
HIF1A Q16665 2/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
THRA P10827 1/20 0.50
THRB P10828 1/20 0.50
NPC1 O15118 3/20 0.49
KMT2A Q03164 2/20 0.49
TRPA1 O75762 1/20 0.47
MAPK1 P28482 1/20 0.47
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46
HSP90AB1 P08238 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8776608 0.84 CYP4F2 (0.62) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL5042255 0.84 KMT2A (0.67) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL7335258 0.83 THRA (0.51) ALDH1A1RAB9AMAPTPOLBSMN1; SMN2
SCHEMBL9294508 0.83 THRA (0.55) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL4113212 0.82 CYP4F2 (0.76) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL8479488 0.82 GSK3B (0.58) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL968517 0.81 CYP4F2 (0.59) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL4019274 0.81 CYP4F2 (0.63) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL1198228 0.79 LOXL2 (0.63) CYP4F2CYP4A11ALDH1A1RAB9AMAPT
SCHEMBL479979 0.79 CYP4F2 (0.61) CYP4F2CYP4A11ALDH1A1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0691959-B1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LTD (GB) 1998-07-22 EP disclosed
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed
US-5728701-A INHIBIT PLATELET AGGREGATION ZENECA LIMITED (GB) 1998-03-17 US disclosed
EP-0825184-A1 Heterocyclic derivatives as platelet aggregation inhibitors ZENECA LIMITED (GB) 1998-02-25 EP disclosed
US-5652242-A 3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BURYIC ACID, AMIDE OR ESTER; INHIBITORS OF BINDING OF FIBRINOGEN TO GLYCOPROTEIN ZENECA LIMITED (GB) 1997-07-29 US disclosed
US-5563141-A INHIBIT CELL ADHESION FOR EXAMPLE, PLATELET AGGRE GATION ZENECA LIMITED (GB) 1996-10-08 US disclosed
US-5556977-A ANTIAGGLOMERANTS FOR CELLS, ANTICOAGULANTS, ANTIISCHEMIC AGENTS USING PYRIDINYLPIPERAZINE DERIVATIVES ZENECA LIMITED (GB) 1996-09-17 US disclosed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 EP disclosed
EP-0690847-A1 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-10 EP disclosed
WO-1994022835-A2 HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO disclosed